XML 46 R36.htm IDEA: XBRL DOCUMENT v3.21.4
Schedule I Condensed Financial Information of Parent Company
12 Months Ended
Dec. 31, 2020
Parent Company [Member]  
Schedule I Condensed Financial Information of Parent Company [Line Items]  
SCHEDULE I CONDENSED FINANCIAL INFORMATION OF PARENT COMPANY
 

December 31,
2019

 

December 31,
2020

Assets

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

5,378

 

 

$

1,600

 

Prepaid expenses and other current assets

 

 

9

 

 

 

126

 

Amount due from subsidiaries

 

 

3,081

 

 

 

3,081

 

Total Current Assets

 

 

8,468

 

 

 

4,807

 

Property, plant and equipment, net

 

 

1

 

 

 

3

 

Other non-current assets

 

 

 

 

 

377

 

Investments in subsidiaries

 

 

 

 

 

6,122

 

Total Assets

 

$

8,469

 

 

$

11,309

 

   

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accrued expenses and other current liabilities

 

$

2

 

 

$

 

Income tax payables

 

 

557

 

 

 

557

 

Amount due to subsidiaries

 

 

12

 

 

 

64,432

 

Total Current Liabilities

 

 

571

 

 

 

64,989

 

Deposit liability for series B2 convertible preferred shares (“Series B2 Preferred”)

 

 

21,792

 

 

 

21,792

 

Deficits of investments in subsidiaries

 

 

28,648

 

 

 

 

Total Liabilities

 

$

51,011

 

 

$

86,781

 

   

 

 

 

 

 

 

 

Mezzanine Equity

 

 

 

 

 

 

 

 

Series C1 convertible redeemable preferred shares (“Series C1 Preferred”) (US$0.0001 par value; 26,757,258 shares authorized, issued and outstanding as of December 31, 2019 and 2020)

 

 

76,684

 

 

 

80,581

 

Series C2 convertible redeemable preferred shares (“Series C2 Preferred”) (US$0.0001 par value; 20,249,450 shares authorized, issued and outstanding as of December 31, 2019 and 2020)

 

 

73,100

 

 

 

81,966

 

Series D1 convertible redeemable preferred shares (“Series D1 Preferred”) (US$0.0001 par value; 22,311,516 shares authorized, issued and outstanding as of December 31, 2019 and 2020)

 

 

127,935

 

 

 

146,583

 

Total Mezzanine Equity

 

$

277,719

 

 

$

309,130

 

   

 

 

 

 

 

 

 

Shareholders’ Deficit

 

 

 

 

 

 

 

 

Ordinary shares (par value of US$0.0001 per share, 240,450,000 shares authorized as of December 31, 2019 and 2020; 99,028,297 shares issued and outstanding as of December 31, 2019 and 2020)

 

$

6

 

 

$

6

 

Additional paid-in capital

 

 

3,727

 

 

 

 

Accumulated deficit

 

 

(314,728

)

 

 

(391,964

)

Accumulated other comprehensive deficit

 

 

(9,266

)

 

 

7,356

 

Total Shareholders’ Deficit

 

 

(320,261

)

 

 

(384,602

)

Total Liabilities, Mezzanine Equity and Shareholders’ Deficit

 

$

8,469

 

 

$

11,309

 

 

Year ended December 31,

   

2018

 

2019

 

2020

Revenues from subsidiaries

 

$

371

 

 

$

289

 

 

$

199

 

Gross profit

 

 

371

 

 

 

289

 

 

 

199

 

   

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative expenses

 

 

(3,909

)

 

 

(2,360

)

 

 

(3,340

)

Total operating expenses

 

 

(3,909

)

 

 

(2,360

)

 

 

(3,340

)

Subsidy income

 

 

 

 

 

 

 

 

224

 

Loss from operations

 

 

(3,538

)

 

 

(2,071

)

 

 

(2,917

)

   

 

 

 

 

 

 

 

 

 

 

 

Other income and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

25

 

 

 

134

 

 

 

38

 

Loss before provision for income taxes

 

 

(3,513

)

 

 

(1,937

)

 

 

(2,879

)

Income tax expense

 

 

(3,309

)

 

 

 

 

 

 

Loss from investment in subsidiaries and variable
interest entities

 

 

(48,070

)

 

 

(55,603

)

 

 

(30,746

)

Net loss attributable to Microvast, Inc.

 

$

(54,892

)

 

$

(57,540

)

 

$

(33,625

)

 

Year ended December 31,

   

2018

 

2019

 

2020

Net loss

 

$

(54,892

)

 

$

(57,540

)

 

$

(33,625

)

   

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive loss, net of tax of nil:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustment

 

 

(30,088

)

 

 

(3,965

)

 

 

16,622

 

Total comprehensive loss

 

$

(84,980

)

 

$

(61,505

)

 

$

(17,003

)

 

Year ended December 31,

   

2018

 

2019

 

2020

Net cash used in operating activities

 

$

(5,416

)

 

$

(6,736

)

 

$

(3,398

)

Net cash used in investing activities

 

 

 

 

 

 

 

 

(380

)

   

 

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities Repurchase shares from former shareholders

 

 

(3,728

)

 

 

 

 

 

 

Net cash used in financing activities

 

 

(3,728

)

 

 

 

 

 

 

Decrease in cash, cash equivalents and restricted cash

 

 

(9,144

)

 

 

(6,736

)

 

 

(3,778

)

Cash, cash equivalents and restricted cash at beginning of the year

 

 

21,258

 

 

 

12,114

 

 

 

5,378

 

Cash, cash equivalents and restricted cash at end of the year

 

$

12,114

 

 

$

5,378

 

 

$

1,600